美拉基因治疗
MGTX
9.28
-0.61
-6.17%
美拉基因治疗
US · MGTX
#3220 按市值排名
上市于 2018
9.28
-0.61
-6.17%
实时 - 追踪5344个代码 - 心跳于47秒前
· 2026-10-16 20:02
最新新闻
-
评级变动
Chardan Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $35\u5e02\u573a\u8d44\u8baf · 2026/5/15
-
评级变动
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $30\u5e02\u573a\u8d44\u8baf · 2026/4/22
-
评级变动
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $16\u5e02\u573a\u8d44\u8baf · 2026/3/27
-
评级变动
Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20\u5e02\u573a\u8d44\u8baf · 2025/12/19
-
评级变动
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $26\u5e02\u573a\u8d44\u8baf · 2026/7/9
-
评级变动
Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $18\u5e02\u573a\u8d44\u8baf · 2026/4/1
-
评级变动
BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $14\u5e02\u573a\u8d44\u8baf · 2026/1/6
-
评级变动
H.C. Wainwright Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $20\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
评级变动
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $26\u5e02\u573a\u8d44\u8baf · 2026/3/27
-
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $27\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
A Quick Look at Today's Ratings for MeiraGTx Holdings(MGTX.US), With a Forecast Between $19 to $30\u5e02\u573a\u8d44\u8baf · 2026/7/8
-
评级变动
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $24\u5e02\u573a\u8d44\u8baf · 2026/4/17
-
评级变动
RBC Capital Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $25\u5e02\u573a\u8d44\u8baf · 2026/5/15
-
Piper Sandler Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $30\u5e02\u573a\u8d44\u8baf · 2026/8/17
-
评级变动
H.C. Wainwright Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20\u5e02\u573a\u8d44\u8baf · 2025/11/24
-
Goldman Sachs Initiates MeiraGTx Holdings(MGTX.US) With Hold Rating, Announces Target Price $16\u5e02\u573a\u8d44\u8baf · 2026/9/25
-
BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Maintains Target Price $19\u5e02\u573a\u8d44\u8baf · 2026/8/14
-
评级变动
Evercore Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Cuts Target Price to $20\u5e02\u573a\u8d44\u8baf · 2025/12/18
-
评级变动
Cantor Fitzgerald Initiates MeiraGTx Holdings(MGTX.US) With Buy Rating, Announces Target Price $20\u5e02\u573a\u8d44\u8baf · 2026/7/9
-
评级变动
BofA Securities Maintains MeiraGTx Holdings(MGTX.US) With Buy Rating, Raises Target Price to $16\u5e02\u573a\u8d44\u8baf · 2026/3/27
新闻标题为自动聚合内容,未经我们团队独立核实或编辑。
报价时间 2026-10-16 20:02:13 · 仅供参考,不构成投资建议,也未考虑您的具体情况。
美拉基因治疗 讨论区 0 条评论